A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist, Naltrexone, in the Treatment of Kleptomania

Biological Psychiatry

Volumn 65, Issue 7, 2009, Pages 600-606

  Grant, Jon E ^a   Kim, Suck Won ^a   Odlaug, Brian L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Impulse control disorders; kleptomania; naltrexone; pharmacotherapy; shoplifting; theft

Indexed keywords

NALTREXONE; OPIATE ANTAGONIST; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INSOMNIA; KLEPTOMANIA; KLEPTOMANIA SYMPTOM ASSESSMENT SCALE; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT RESPONSE; XEROSTOMIA; YALE BROWN OBSESSIVE COMPULSIVE SCALE FOR KLEPTOMANIA;

ADOLESCENT; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PLACEBOS; SEVERITY OF ILLNESS INDEX; THEFT;

EID: 61549141064     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.11.022     Document Type: Article

References (44)

1. McElroy S.L., Pope Jr. H.G., Hudson J.I., Keck Jr. P.E., and White K.L. Kleptomania: A report of 20 cases. Am J Psychiatry 148 (1991) 652-657
2. Aboujaoude E., Gamel N., and Koran L.M. Overview of kleptomania and phenomenological description of 40 patients. Prim Care Companion J Clin Psychiatry 6 (2004) 244-247
3. Goldman M.J. Kleptomania: Making sense of the nonsensical. Am J Psychiatry 148 (1991) 986-996
4. Grant J.E., and Kim S.W. Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Compr Psychiatry 43 (2002) 378-384
5. Grant J.E., and Potenza M.N. Gender-related differences in individuals seeking treatment for kleptomania. CNS Spectr 13 (2008) 235-245
6. National Association for Shoplifting Prevention. Shoplifting statistics (2006). http://www.shopliftingprevention.org/WhatNASPOffers/NRC/PublicEducStats.htm Accessed July 25, 2008
7. Blanco C., Grant J., Petry N.M., Simpson H.B., Alegria A., Liu S.M., and Hasin D. Prevalence and correlates of shoplifting in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Am J Psychiatry 165 (2008) 905-913
8. Odlaug B.L., and Grant J.E. Prevalence of impulse control disorders in a college sample (2008) Presented at the Annual Meeting of the American Psychiatric Association, May 2008, Washington, DC. NR2-069 [poster]
9. Grant J.E., Levine L., Kim D., and Potenza M.N. Prevalence of impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 162 (2005) 2184-2188
10. Lejoyeux M., Feuché N., Loi S., Solomon J., and Adès J. Study of impulse-control disorders among alcohol-dependent patients. J Clin Psychiatry 60 (1999) 302-305
11. Lejoyeux M., Arbaretaz M., McLoughlin M., and Adès J. Impulse control disorders and depression. J Nerv Ment Dis 190 (2002) 310-314
12. Esquirol E. Des Maladies Mentales (1838), Bailliere, Paris
13. Grant J.E., and Odlaug B.L. Kleptomania: Clinical characteristics and treatment. Rev Bras Psiquiatr 30 suppl 1 (2008) S11-S15
14. Grant J.E. Family history and psychiatric comorbidity in persons with kleptomania. Compr Psychiatry 44 6 (2003) 437-441
15. Volpicelli J.R., Alterman A.I., Hayashida M., and O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49 (1992) 876-880
16. Anton R.F., Moak D.H., Waid L.R., Latham P.K., Malcolm R.J., and Dias J.K. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial. Am J Psychiatry 156 (1999) 1758-1764
17. Martin W.R., Jasinski D., and Mansky P. Naltrexone, an antagonist for the treatment of heroin dependence. Arch Gen Psychiatry 23 (1973) 784-789
18. Kosten T.R., Kleber H.D., and Morgan C. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 44 (1989) 887-892
19. Ikemoto S., Glazier B.S., Murphy J.M., and McBride W.J. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J Neurosci 17 (1997) 8580-8587
20. Kim S.W., Grant J.E., Adson D.E., and Shin Y.C. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 49 (2001) 914-921
21. Mason B.J., Salvato F.R., Williams L.D., Ritvo E.C., and Cutler R.B. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 56 (1999) 719-724
22. Stewart J. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol Biochem Behav 20 (1984) 917-923
23. Matthews R.T., and German D.C. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience 11 (1984) 617-625
24. Broekkamp C.L., and Phillips A.G. Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area. Pharmacol Biochem Behav 11 (1979) 289-295
25. Grant J.E., and Kim S.W. An open label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry 63 (2002) 349-356
26. Koran L.M., Aboujaoude E.N., and Gamel N.N. Escitalopram treatment of kleptomania: An open-label trial followed by double-blind discontinuation. J Clin Psychiatry 68 (2007) 422-427
27. Matthews R.T., and German D.C. Electrophysiological evidence for excitation of rat ventral tegmental area and dopamine neurons by morphine. Neuroscience 11 (1984) 617-625
28. Stewart J. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol Biochem Behav 20 (1984) 917-923
29. Grant J.E., Kim S.W., and McCabe J. Structured Clinical Interview for Kleptomania (SCI-K): Peliminary validity and reliability testing. Int J Methods Psychiatr Res 15 (2006) 83-94
30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
31. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 32 (1959) 50-55
32. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV-Patient Edition (1995), Biometrics Research Department, New York State Psychiatric Institute (SCID-I/P, Version 2.0), New York
33. Sheehan D.V. The Anxiety Disease (1983), Scribner's, New York
34. Kim S.W. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 59 (1998) 159-164
35. Grant J.E., Kim S.W., and Hartman B.K. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry 69 (2008) 783-789
36. Guy W. ECDEU Assessment Manual for Psychopharmacology (1976), National Institute of Mental Health. U.S. Dept Health, Education and Welfare publication (ADM), Rockville, Maryland 76-338, 218-222
37. Davison A.C., and Hinkley D.V. Bootstrap Methods and Their Application (1997), Cambridge University Press, Cambridge, United Kingdom
38. Grant J.E., Potenza M.N., Hollander E., Cunningham-Williams R., Nurminen T., Smits G., and Kallio A. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 163 (2006) 303-312
39. Mason B.J., Salvato F.R., Williams L.D., Ritvo E.C., and Cutler R.B. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 56 (1999) 719-724
40. Anton R.F., O'Malley S.S., Ciraulo C.C., Cisler R.A., Couper D., Donovan D.M., et al., COMBINE Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. JAMA 295 (2006) 2003-2017
41. Potenza M.N. Should addictive disorders include non-substance-related conditions?. Addiction 101 suppl 1 (2006) 142-151
42. Srisurapanont M., and Jarusuraisin N. Naltrexone for the treatment of alcoholism: A meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 8 (2005) 267-280
43. Grant J.E. Outcome study of kleptomania patients treated with naltrexone: A chart review. Clin Neuropharmacol 28 (2005) 11-14
44. Dannon P.N., Lowengrub K.M., Iancu I., and Kotler M. Kleptomania: Comorbid psychiatric diagnosis in patients and their families. Psychopathology 37 (2004) 76-80